{"altmetric_id":1972936,"counts":{"readers":{"mendeley":28,"citeulike":0,"connotea":0},"total":{"posts_count":3},"twitter":{"unique_users_count":3,"unique_users":["HTACanada","drddawoud","Fundament_AS"],"posts_count":3}},"citation":{"abstract":"The aim of this study was to develop and apply an instrument to map the level of health technology assessment (HTA) development at country level in selected countries. We examined middle-income countries (Argentina, Brazil, India, Indonesia, Malaysia, Mexico, and Russia) and countries well-known for their comprehensive HTA programs (Australia, Canada, and United Kingdom).","abstract_source":"pubmed","altmetric_jid":"4f6fa6003cf058f610006257","authors":["Wija Oortwijn","Pieter Broos","Hindrik Vondeling","David Banta","Lora Todorova"],"doi":"10.1017\/s0266462313000469","first_seen_on":"2013-12-11T19:12:32+00:00","issns":["1471-6348"],"issue":"4","journal":"International Journal of Technology Assessment in Health Care","last_mentioned_on":1386856892,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24290336","http:\/\/journals.cambridge.org\/action\/displayAbstract?fromPage=online&aid=9090952&fulltextType=RA&fileId=S0266462313000469"],"pmid":"24290336","pubdate":"2013-10-01T00:00:00+00:00","publisher_subjects":[{"name":"Public Health And Health Services","scheme":"era"},{"name":"Applied Economics","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["healthservicesresearch"],"title":"Mapping of health technology assessment in selected countries.","type":"article","volume":"29","mendeley_url":"http:\/\/www.mendeley.com\/research\/mapping-health-technology-assessment-selected-countries"},"altmetric_score":{"score":1.85,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.85},"context_for_score":{"all":{"total_number_of_other_articles":5034930,"mean":5.9653228424835,"rank":2162700,"this_scored_higher_than_pct":55,"this_scored_higher_than":2801951,"rank_type":"exact","sample_size":5034930,"percentile":55},"similar_age_3m":{"total_number_of_other_articles":133285,"mean":7.4046210647944,"rank":48361,"this_scored_higher_than_pct":62,"this_scored_higher_than":82760,"rank_type":"exact","sample_size":133285,"percentile":62},"this_journal":{"total_number_of_other_articles":363,"mean":2.2401436464088,"rank":141,"this_scored_higher_than_pct":60,"this_scored_higher_than":219,"rank_type":"exact","sample_size":363,"percentile":60},"similar_age_this_journal_3m":{"total_number_of_other_articles":3,"mean":2.625,"rank":2,"this_scored_higher_than_pct":33,"this_scored_higher_than":1,"rank_type":"exact","sample_size":3,"percentile":33}}},"demographics":{"poster_types":{"member_of_the_public":3},"users":{"twitter":{"cohorts":{"Members of the public":3}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":9,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":8,"Student  > Postgraduate":1,"Other":2,"Student  > Master":6},"by_discipline":{"Engineering":1,"Medicine and Dentistry":11,"Social Sciences":7,"Decision Sciences":1,"Economics, Econometrics and Finance":4,"Nursing and Health Professions":1,"Business, Management and Accounting":1,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"CA":1,"GB":1},"mendeley":{"JP":1,"ES":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/HTACanada\/status\/410849191817412608","license":"public","rt":["health_medical_"],"citation_ids":[1972936],"posted_on":"2013-12-11T19:10:55+00:00","author":{"name":"HTACanada","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000601349581\/f997b6fd6156d0dadd7b228389470685_normal.jpeg","description":"Research and insights on HTA in Canada. Join our group on LinkedIn for networking opportunities.","id_on_source":"HTACanada","tweeter_id":"1588972196","geo":{"lt":60.10867,"ln":-113.64258,"country":"CA"},"followers":1261},"tweet_id":"410849191817412608"},{"url":"http:\/\/twitter.com\/drddawoud\/status\/410851979205038080","license":"public","rt":["HTACanada","health_medical_"],"citation_ids":[1972936],"posted_on":"2013-12-11T19:21:59+00:00","author":{"name":"Dalia M Dawoud","image":"https:\/\/pbs.twimg.com\/profile_images\/2302513701\/91ujvr8ih1u5k36jno12_normal.jpeg","description":"Senior Health Economist\/lecturer. NGC (NICE guideline development cente) Main interests: pharmacoeconomics, pharmacy practice and policy research. Views my own.","id_on_source":"drddawoud","tweeter_id":"74711006","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":659},"tweet_id":"410851979205038080"},{"url":"http:\/\/twitter.com\/Fundament_AS\/status\/411133722680098816","license":"public","citation_ids":[1972936],"posted_on":"2013-12-12T14:01:32+00:00","author":{"name":"AETSA","url":"http:\/\/www.aetsa.org","image":"https:\/\/pbs.twimg.com\/profile_images\/450360727912468480\/CzyPgjrt_normal.png","description":"\u2014\u2014Agencia de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias de Andaluc\u00eda\u2014\u2014 Ayudando a la toma de decisiones en salud","id_on_source":"Fundament_AS","tweeter_id":"720656903","geo":{"lt":null,"ln":null},"followers":1292},"tweet_id":"411133722680098816"}]}}